Details for New Drug Application (NDA): 006927
✉ Email this page to a colleague
NDA 006927 describes EURAX, which is a drug marketed by Journey and is included in two NDAs. It is available from one supplier. Additional details are available on the EURAX profile page.
The generic ingredient in EURAX is crotamiton. There are six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the crotamiton profile page.
The generic ingredient in EURAX is crotamiton. There are six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the crotamiton profile page.
Summary for 006927
| Tradename: | EURAX |
| Applicant: | Journey |
| Ingredient: | crotamiton |
| Patents: | 0 |
Suppliers and Packaging for NDA: 006927
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| EURAX | crotamiton | CREAM;TOPICAL | 006927 | NDA | Journey Medical Corporation | 69489-311 | 69489-311-60 | 1 TUBE in 1 CARTON (69489-311-60) / 60 g in 1 TUBE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CREAM;TOPICAL | Strength | 10% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
